GLUT inhibitor WZB117 induces cytotoxicity with increased production of amyloid-beta peptide in SH-SY5Y cells preventable by beta-hydroxybutyrate: implications in Alzheimer's disease.
Gourav ChandanUpasana GangulySoumya PalSukhpal SinghReena V SainiSankha Shubhra ChakrabartiAdesh K SainiSasanka ChakrabartiPublished in: Pharmacological reports : PR (2023)
Results in this neuroblastoma model have implications for the pathogenesis of Alzheimer's disease and warrant further explorations of WZB117 in primary cultures of neurons and experimental animal models.